Data may be delayed — last successful sync 2026-09-26 (18 days ago). Figures reflect the most recent completed ingest.
Company profile
Spectral AI, Inc.
NASDAQ: MDAI · Healthcare · Medical - Specialties
#546 of 1,417 Healthcare companies by revenuebottom-quartile growth
EA Score
39DFH 48DQ 27GM 36SS 45
v0.1 · 65/100 weight · provisional
↑ market scale, net margin · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$15.2M
Rev growth YoY (TTM)
-45.0%
Net income (FY)
-$7.6M
Employees
65
as of 2026-09-17
Market cap
$49.3M
as of 2026-09-17
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$19.6M$19.6M2025
Net income-$7.6M-$7.6M2025
Operating income-$8.6M-$8.6M2025
Total assets$21.4M$21.4M2025
Liabilities$27.1M$27.1M2025
Equity-$5.7M-$5.7M2025
Revenue trend
FY2023 – FY2025 · USD
FY23
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Spectral AI, Inc.’s revenue?
Spectral AI, Inc. booked $19.6M in FY2025 revenue, contracting 34% year over year — slower than 76% of Healthcare companies we track, at a -38.5% net margin.
Peers · Healthcare
Acutus Medical, Inc.——Nutrition Management Services Company——Immix Biopharma, Inc.49DCarisma Therapeutics, Inc.——Sonoma Pharmaceuticals, Inc.60CAvem Health Partners, Inc.——Neighbors
Dallas →Key facts
CEOVincent S. Capone
SectorHealthcare
IndustryMedical - Specialties
HeadquartersDallas, TX
ExchangeNASDAQ: MDAI
Employees65
IPO date2021-04-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.